Merck Animal Health to Acquire U.S. Rights to SENTINEL® Brand of Combination Parasiticides for Companion Animals
Further Solidifies Merck Animal Health’s Position in the U.S. Companion Animal Category with Comprehensive, Continuous Parasite Protection
Complements Merck Animal Health’s Broad Portfolio of Vaccines and Pharmaceuticals
MADISON, N.J.–(BUSINESS WIRE)–Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), and Virbac (NYSE Euronext:VIRP) today announced that the companies have signed a definitive agreement under which Merck Animal Health would acquire the U.S. rights to SENTINEL® FLAVOR TABS® and SENTINEL® SPECTRUM® Chews in the Companion Animal category.
Merck
Media:
Noreen Verbrugge
+ 1 (973) 937-5450
[email protected]
Pam Eisele
+1 (267) 305-3558
[email protected]
Merck
Investors:
Michael DeCarbo
+ 1 (908) 740-1807
[email protected]
